{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:41:10Z","timestamp":1760589670867,"version":"build-2065373602"},"reference-count":42,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["U19-AI166761"],"award-info":[{"award-number":["U19-AI166761"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Margaret Batts Tobin Foundation, San Antonio, TX"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Coccidioides immitis and Coccidioides posadasii, the causative agents of coccidioidomycosis, represent a major public health concern in endemic regions of North and South America. The disease spectrum ranges from mild respiratory illness to severe disseminated infections, with thousands of cases reported annually in the United States and an increasing recognition of its global impact. Despite existing antifungal therapies, treatment remains challenging due to toxicity, drug resistance, and limited therapeutic options. High-throughput screening platforms have revolutionized drug discovery for infectious diseases; however, progress in antifungal screening for Coccidioides spp. has been hampered by the requirement for Biosafety Level 3 (BSL-3) containment. To overcome these barriers, we leveraged an attenuated C. posadasii strain that can be safely handled under BSL-2 conditions. Here, we describe the development and optimization of 96-well and 384-well plate screening methodologies, providing a safer and more efficient platform for antifungal discovery. This approach enhances the feasibility of large-scale screening efforts and may facilitate the identification of novel therapeutics for coccidioidomycosis.<\/jats:p>","DOI":"10.3390\/jof11100733","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:57:42Z","timestamp":1760529462000},"page":"733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Optimization of Multi-Well Colorimetric Assays for Growth of Coccidioides posadasii Spherules and Their Application in Large-Scale Screening"],"prefix":"10.3390","volume":"11","author":[{"given":"Augusto","family":"Vazquez-Rodriguez","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-3366","authenticated-orcid":false,"given":"Jieh-Juen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1091-3420","authenticated-orcid":false,"given":"Chiung-Yu","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-3270","authenticated-orcid":false,"given":"Jose L.","family":"Lopez-Ribot","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40121-022-00606-y","article-title":"Coccidioidomycosis: A contemporary review","volume":"11","author":"Crum","year":"2022","journal-title":"Infect. Dis. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Thompson, G.R., and Chiller, T.M. (2022). Endemic Mycoses: Underdiagnosed and Underreported, American College of Physicians.","DOI":"10.7326\/M22-2371"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kirkland, T.N., Stevens, D.A., Hung, C.Y., Beyhan, S., Taylor, J.W., Shubitz, L.F., Duttke, S.H., Heidari, A., Johnson, R.H., and Deresinski, S.C. (2022). Coccidioides Species: A Review of Basic Research: 2022. J. Fungi, 8.","DOI":"10.3390\/jof8080859"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/jac\/dkaf002","article-title":"Coccidioidomycosis: A growing global concern","volume":"80","author":"Donovan","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.26574\/maedica.2023.18.2.209","article-title":"Spinal Infections Caused by Coccidioides Species","volume":"18","author":"Koutserimpas","year":"2023","journal-title":"Maedica"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Koutserimpas, C., Naoum, S., Raptis, K., Vrioni, G., Samonis, G., and Alpantaki, K. (2022). Skeletal infections caused by Coccidioides species. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030714"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moni, B.M., Wise, B.L., Loots, G.G., and Weilhammer, D.R. (2023). Coccidioidomycosis osteoarticular dissemination. J. Fungi, 9.","DOI":"10.20944\/preprints202303.0030.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6807a1","article-title":"Surveillance for coccidioidomycosis\u2014United States, 2011\u20132017","volume":"68","author":"Benedict","year":"2019","journal-title":"MMWR Surveill. Summ."},{"key":"ref_9","unstructured":"Centers for Disease Control and Prevention (2024). Valley Fever (Coccidioidomycosis) Statistics, Available online: https:\/\/www.cdc.gov\/valley-fever\/php\/statistics\/index.html."},{"key":"ref_10","unstructured":"World Health Organization (2022). WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, Organizaci\u00f3n Mundial de la Salud (OMS)."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14787210.2016.1199272","article-title":"Antifungal agents and liver toxicity: A complex interaction","volume":"14","author":"Tverdek","year":"2016","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_12","first-page":"603","article-title":"Antifungal agents for the treatment of systemic fungal infections in children","volume":"15","author":"Allen","year":"2010","journal-title":"Paediatr. Child Health"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Souza, A.C., and Amaral, A.C. (2017). Antifungal therapy for systemic mycosis and the nanobiotechnology era: Improving efficacy, biodistribution and toxicity. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00336"},{"key":"ref_14","first-page":"14","article-title":"High-throughput screening for drug discovery","volume":"384","author":"Broach","year":"1996","journal-title":"Nature"},{"key":"ref_15","first-page":"2","article-title":"High-throughput screening: The hits and leads of drug discovery-an overview","volume":"1","author":"Martis","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ayon, N.J. (2023). High-throughput screening of natural product and synthetic molecule libraries for antibacterial drug discovery. Metabolites, 13.","DOI":"10.3390\/metabo13050625"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","article-title":"Drug repurposing against antibiotic resistant bacterial pathogens","volume":"279","author":"Aggarwal","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coph.2019.07.006","article-title":"Improving therapy of severe infections through drug repurposing of synergistic combinations","volume":"48","author":"Cheng","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ramage, G., and Andes, D. (2025). Large-Scale Phenotypic Screenings of Repurposing Libraries to Identify Drugs with Novel Antifungal Activity Against Candida Biofilms. Fungal Biofilms, Springer Nature.","DOI":"10.1007\/978-3-031-93315-8"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Garcia, J.A., Vu, K., Thompson, G.R., and Gelli, A. (2022). Characterization of the growth and morphology of a BSL-2 Coccidioides posadasii strain that persists in the parasitic life cycle at ambient CO2. J. Fungi, 8.","DOI":"10.1101\/2022.03.29.486294"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1535676019856525","article-title":"Heat Inactivation of Coccidioides posadasii and Coccidioides immitis for use in lower biosafety containment","volume":"24","author":"Mead","year":"2019","journal-title":"Appl. Biosaf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/jb.78.2.231-239.1959","article-title":"Nutrition of the parasitic phase of Coccidioides immitis in a chemically defined liquid medium","volume":"78","author":"Converse","year":"1959","journal-title":"J. Bacteriol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Schwab, M. (2017). Z-Factor. Encyclopedia of Cancer, Springer.","DOI":"10.1007\/978-3-662-46875-3"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/02681218680000281","article-title":"Electron-microscopic observations of the Coccidioides immitis parasitic cycle in vivo","volume":"24","author":"Sun","year":"1986","journal-title":"J. Med. Vet. Mycol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e00205-25","DOI":"10.1128\/mbio.00205-25","article-title":"Discovery of novel antifungal drugs via screening repurposing libraries against Coccidioides posadasii spherule initials","volume":"16","author":"Saeger","year":"2025","journal-title":"mBio"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Coma, I., Herranz, J., and Martin, J. (2009). Statistics and Decision Making in High-Throughput Screening. High Throughput Screening: Methods and Protocols, Humana Press. [2nd ed.].","DOI":"10.1007\/978-1-60327-258-2_4"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/apm.13342","article-title":"Screening the medicine for malaria venture\u2019s Pandemic Response Box to identify novel inhibitors of Candida albicans and Candida auris biofilm formation","volume":"131","author":"Ajetunmobi","year":"2023","journal-title":"APMIS"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ajetunmobi, O.H., Wall, G., Vidal Bonifacio, B., Martinez Delgado, L.A., Chaturvedi, A.K., Najvar, L.K., Wormley, F.L., Patterson, H.P., Wiederhold, N.P., and Patterson, T.F. (2023). High-throughput screening of the repurposing hub library to identify drugs with novel inhibitory activity against Candida albicans and Candida auris biofilms. J. Fungi, 9.","DOI":"10.3390\/jof9090879"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/21505594.2016.1235653","article-title":"Antifungal therapeutics for dimorphic fungal pathogens","volume":"8","author":"Goughenour","year":"2017","journal-title":"Virulence"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Thompson, G.R., Barker, B.M., and Wiederhold, N.P. (2017). Large-scale evaluation of in vitro amphotericin B, triazole, and echinocandin activity against Coccidioides species from US institutions. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.02634-16"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhou, Z.X., Yin, X.D., Zhang, Y., Shao, Q.H., Mao, X.Y., Hu, W.J., Shen, Y.L., Zhao, B., and Li, Z.L. (2022). Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.891336"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Xiang, Z.J., Yang, J.H., Wang, W.J., Xu, Z.C., and Xiang, R.L. (2021). Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.697330"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e70004","DOI":"10.1002\/wcms.70004","article-title":"Strategies for Redesigning Withdrawn Drugs to Enhance Therapeutic Efficacy and Safety: A Review","volume":"15","author":"Patel","year":"2025","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wall, G., and Lopez-Ribot, J.L. (2020). Screening repurposing libraries for identification of drugs with novel antifungal activity. Antimicrob. Agents Chemother., 64.","DOI":"10.1128\/AAC.00924-20"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1386207326666230705150110","article-title":"Design and Diversity analysis of chemical libraries in drug discovery","volume":"27","author":"Olmedo","year":"2024","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e01008-24","DOI":"10.1128\/spectrum.01008-24","article-title":"In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides","volume":"12","author":"Mead","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/mmy\/myy049","article-title":"Characterizing in vitro spherule morphogenesis of multiple strains of both species of Coccidioides","volume":"57","author":"Mead","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12033-010-9335-9","article-title":"Design and implementation of high throughput screening assays","volume":"47","author":"Hertzberg","year":"2011","journal-title":"Mol. Biotechnol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/10\/733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T04:18:26Z","timestamp":1760588306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/10\/733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jof11100733"],"URL":"https:\/\/doi.org\/10.3390\/jof11100733","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2025,10,11]]}}}